Equities

GT Biopharma Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

GT Biopharma Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.5389
  • Today's Change0.042 / 8.54%
  • Shares traded989.20k
  • 1 Year change-75.39%
  • Beta1.2956
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Friday, GT Biopharma Inc (GTBP:NAQ) closed at 0.5389, 34.36% above the 52 week low of 0.4011 set on Feb 02, 2026.
52-week range
Today
0.4011Feb 02 20263.85Jun 27 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.48
High0.540
Low0.4548
Bid0.5227
Offer0.5301
Previous close0.4965
Average volume1.86m
Shares outstanding26.65m
Free float25.92m
P/E (TTM)--
Market cap13.23m USD
EPS (TTM)-3.38
USD
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼

Events & Activity

  • GTBP:NAQ trading volume exceeds daily average by +190.93%
  • GTBP:NAQ price moved over +5.51% to 0.5384
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.